This negative modulation of ENT1 and dCK gene expression aligns with findings in the cytarabine-resistant HL-60 human leukemic cell line and in chemoresistant acute myeloid leukemia samples [31,36]. This evidence concerns the gene DCK and acute myeloid leukemia.